Replies to post #533 on Momenta Pharmaceuticals, Inc. (MNTA)

[y3maxx]

DFRAI...Since the shorters know now the threat is not TEVA's t'enox, nor that M'enox's sales are weak, then we must logically deduce M'enox's profit margin is not as high as expected.

My previous posts were put out there as food for thought.

y3